HysensBio is developing a first-in-class therapeutics for the most common dental disease in the world. With over 20 years of fundamental dental research HysensBio has developed the world’s first technology to regenerate physiologic dentin and periodontal ligament. Through this, we are opening a new area in the treatment of dental diseases, such as dentin hypersensitivity, dental caries and periodontal disease.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 2fl, Mansan Bldg, 10 Dwitgol-Ro, Gwacheon,gyeonggido 13814,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.hysensbio.com
- Keywords
- Bio Tech, Dental Disease treatment, First-in-class drug, Dental Hypersenstivity, Dental Caries, Periodontal Ligament Disease, Animal Dental Drug.
- HQ
- Gwacheon, Gyeonggido
Hysensbio Questions
Hysensbio's website is http://www.hysensbio.com
Hysensbio's LinkedIn profile is https://kr.linkedin.com/company/hysensbio
Hysensbio has
12 employees.
View email and phone details for 12
employees at Hysensbio.
Hysensbio's industry is
Biotechnology Research
Hysensbio's top competitors are
Radahaim,
Bespin Global China,
하나금융투자,
Slate Flosser,
Esther Formula (에스더포뮬러),
Asia Medical Solutions (Ams),
Kolon Pharma,
Dentherapy Limited,
Brexogen Inc.,
하이센스바이오.
Hysensbio's categories are Biotechnology Research
Hysensbio's founding year is 2016
